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Abstract 
Catechin gallates have weak direct antibacterial activity but are able to substantially and reversibly 
modify the properties of multi-drug-resistant Staphylococcus aureus, a problematical opportunistic 
pathogen responsible for an enormous number of hospital-acquired and community infections 
worldwide. In particular, MRSA strains that have acquired resistance genes to β-lactam antibiotics, 
the penicillins and cephalosporins, compromise the therapeutic utility of these frontline drugs. 
Resistance to β-lactam agents can be completely abrogated by exposure of MRSA strains to catechin 
gallates, particularly (-)-epicatechin gallate (ECg); the compounds also prevent formation of biofilms 
and substantially reduce the virulence of MRSA. We have shown that the complex, ECg-induced 
staphylococcal phenotype is due to intercalation of ECg into the cytoplasmic membrane of the 
bacterial cells; incorporation of molecules deep within the hydrophobic core of the lipid palisade 
forces a reconfiguration of the membrane to provide a sub-optimal environment for proteins 
embedded in the staphylococcal membrane. In particular, the orderly function of the septal division 
machinery in MRSA, incorporating the penicillin binding protein PBP2a responsible for β-lactam 
resistance, is compromised leading to loss of resistance to all β-lactam antibiotics. Catechin gallates 
are attractive candidates as adjuncts to conventional antibacterial chemotherapy but improvements 
in stability, absorption and pharmacokinetic profile through chemical engineering would 
substantially increase their potential as agents for therapeutic intervention. 
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Introduction 
The rising incidence of antibiotic resistance in both Gram-positive and Gram-negative bacteria poses 
a serious threat to global health, compounded by the paucity of new antibiotics in the drug 
development pipeline. The ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species) have 
been highlighted as the primary threats to human health associated with antibiotic resistance and 
acquisition of multi-drug resistance appears to be intrinsic to their success (Boucher et al., 2009). 
Multi-drug resistant bacteria have emerged due to the intense selective pressure on bacterial 
populations within hospitals and communities brought about by the use and overuse of frontline 
antibiotics. The emergence of resistance to conventional antibiotics, that kill or inhibit the growth of 
pathogens and commensals alike, is inevitable  and provides a dramatic demonstration of Darwin’s 
insights into evolution through natural selection. The spread of antibiotic resistance is further 
exacerbated by the capacity of many pathogens to acquire antibiotic resistance genes through 
horizontal gene transfer.  
As a novel approach to the treatment of difficult-to-treat bacterial infections, we have 
examined the therapeutic potential of agents that do not directly kill the target bacterial population 
but modify them to produce a “less fit” phenotype with reduced capacity to survive at the site of 
infection (Taylor et al., 2009). There are conceptual reasons to suppose that this approach will result 
in less selective pressure on the bacteria and delay the emergence of resistant genotypes (Tan et al., 
2000). We have focused on S. aureus, a leading cause of hospital-acquired and community-acquired 
infections worldwide; this highly successful opportunistic pathogen is a common component of the 
resident bacterial population (microbiota) of the upper respiratory tract and skin of healthy 
individuals but also causes a variety of infections ranging from minor skin conditions to life-
threatening diseases such as endocarditis, septicaemia and toxic shock syndrome (Thwaites et al., 
2011). Multi-drug-resistant forms are typified by methicillin-resistant S. aureus (MRSA) that are 
represented by a limited number of successful clones that dominate worldwide in hospitals and 
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communities and are invariably resistant  to all β-lactam antibiotics due to acquisition of mecA or 
mecC genes encoding the low-affinity penicillin binding protein PBP2a (Fuda et al., 2005; Paterson et 
al., 2014). MRSA strains are particularly adept at acquiring genes conferring resistance to a wide 
variety of antibiotics, considerably eroding their utility for the fight against serious infections caused 
by this pathogen.  
Modulation of β-lactam resistance and other properties of MRSA by catechin gallates 
Extracts of green tea (Hamilton-Miller, 1997) and their major individual components (Stapleton et 
al., 2004) have a relatively weak capacity to inhibit and kill a wide range of pathogenic bacteria at or 
slightly below typical concentrations found in brewed tea. However, green tea extracts have the 
capacity to reverse methicillin resistance in MRSA at concentrations much lower than those needed 
to produce inhibition of bacterial growth (Yam et al., 1998). Subsequent examination of the major 
bioactive components revealed that abrogation of β-lactam resistance was attributable to the 
catechin gallates, with (-)-epicatechin gallate (ECg) showing greater potency than either (-)-
epigallocatechin gallate (EGCg) or (-)-catechin gallate (Cg); the effect was wide-ranging, with all forty 
MRSA isolates examined sensitised to a comprehensive selection of β-lactam chemical structures 
(Stapleton et al., 2004). Japanese groups also showed that ECg (Shiota et al., 1999) and EGCg (Zhao 
et al., 2001) significantly reduce the minimum inhibitory concentration (MIC) of methicillin, oxacillin 
and other β-lactam antibiotics in MRSA. ECg reduced the MIC of β-lactams for MRSA strains from full 
resistance (256-512 mg/l) to below the antibiotic breakpoint (~1 mg/l) where drugs are assumed to 
possess clinical efficacy (Stapleton et al., 2004; Yam et al., 1998), raising the possibility that such 
molecules could be used in combination with β-lactam agents to treat MRSA infections. We also 
found that ECg reduced the secretion by the common epidemic strain EMRSA-16 of a range of 
proteins such as the toxins and tissue-degrading enzymes the pathogen needs to spread through the 
body and cause harm (Shah et al., 2008), and prevented the formation of biofilms (Stapleton et al., 
2007), an interfacial mode of growth essential for colonisation of natural and artificial surfaces. ECg 
also abrogates halotolerance in S. aureus by interference with cation (Na+[Li+]/H+) ion-specific 
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antiporter systems in the cytoplasmic membrane (CM) (Stapleton et al., 2006a). These properties 
raise the intriguing possibility than ECg could function alone to “disarm” highly pathogenic 
staphylococci. Growth of MRSA in the presence of moderate concentrations of ECg has a profound 
impact on the appearance of the bacterial cells (Fig. 1): the compound increases the thickness of the 
staphylococcal cell wall and stimulates the formation of pseudomulticellular aggregates in which 
dividing cocci do not separate cleanly into daughter cells (Stapleton et al., 2007). 
Interactions of ECg and MRSA cells 
ECg and other galloyl catechins have a broad ranging impact on staphylococci due to their capacity 
to intercalate in non-lethal fashion into the bacterial CM (Bernal et al., 2010; Palacios et al., 2014). 
Their relative affinity for model lipid bilayers (Caturla et al., 2003; Kajiya et al., 2001; Kajiya et al., 
2002) reflects both their partition coefficients in n-octanol-saline (Hashimoto et al., 1999) and their 
capacity to modulate β-lactam resistance (Stapleton et al., 2004). Thus, ECg binds more avidly than 
EGCg, Cg and the non-galloyl counterparts (-)-epicatechin (EC) and (-)-epigallocatechin (EGC); EC and 
EGC exert no β-lactam-modifying capacity but can enhance the membrane binding and bioactivity of 
ECg (Palacios et al., 2014; Stapleton et al., 2006b). Interactions between lipid bilayers and ECg are 
facilitated by an exposed hydrophobic domain in the region of the ester bond and C-ring, optimized 
by virtue of epi (cis) stereochemistry. We studied the binding of ECg and other catechins to artificial 
membranes modelled on the lipid composition of the staphylococcal bilayer and showed that ECg 
adopts a position deep within the lipid palisade, eliciting major alterations in the thermotropic and 
anisotropic behaviour of the bilayer. These data reflect the binding of ECg to the staphylococcal 
bilayer: the S. aureus CM is unusual (Haest et al., 1972; Mukhopadhyay et al., 2007) comprising 
three major phospholipids, negatively charged phosphatidylglycerol (PG) and cardiolipin in addition 
to positively charged lysyl-PG distributed with a high degree of asymmetry across the outer and 
inner leaflets of the lipid palisade (Mukhopadhyay et al., 2007; Rosado et al., 2015). Intercalation of 
ECg into the CM alters the expression of genes encoding membrane-embedded proteins and up-
regulates genes belonging to the cell wall stress stimulon (Bernal et al., 2010), indicating that the 
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bacteria respond to ECg binding by taking steps to preserve and repair a compromised cell wall and 
membrane. 
How does ECg binding to the CM elicit substantial changes to the structure and physiology of 
MRSA? ECg molecules rapidly enter the CM, inducing an immediate reduction in fluidity, but the 
bacteria respond by altering the composition of the membrane, incorporating a greater complement 
of branched chain fatty acids to re-establish a fluid phospholipid palisade whilst retaining membrane 
asymmetry (Bernal et al., 2010; Rosado et al., 2015). However, these changes result in a more fluid 
structure that is likely to provide a sub-optimal environment for integral membrane proteins. In the 
case of the Na+[Li+]/H+ antiport, this would almost certainly result in a loss of ability to accumulate 
osmoprotective molecules and a loss of tolerance to salt. Similarly, efficient protein export requires 
an optimally-configured CM (Sibbald et al., 2006). ECg reduces the net positive charge of the 
staphylococcal surface, in part due to its capacity to inhibit the attachment of D-alanine residues to 
peptidoglycan-associated wall teichoic acids (Bernal et al., 2009); these anionic glycopolymers play 
crucial roles in cell shape determination, regulation of cell division, staphylococcal pathogenesis and 
antibiotic resistance (Brown et al., 2013). Positive surface charge is also likely to be further reduced 
as a consequence of ECg-mediated reduction in the biosynthetic activity of membrane-anchored 
MprF, an enzyme that attaches positively-charged lysine to PG; ECg membrane intercalation elicits a 
large decrease in lysyl-PG in the lipid palisade (Bernal et al., 2010). An increased negative surface 
charge leads to electrostatic repulsion from negatively charged surfaces and probably accounts for 
the biofilm-inhibiting properties of ECg. 
Perturbation of orderly cell division, cell wall turnover and cell separation following growth 
in ECg-supplemented medium (Stapleton et al., 2007) are in all likelihood due to changes in the 
secretion of staphylococcal autolysins (peptidoglycan hydrolases); these enzymes sculpt the shape, 
size and thickness of cell wall peptidoglycan and facilitate separation of daughter cells during and 
after cell division, often following secretion into the external milieu (Wheeler et al., 2015). ECg-
grown cells retained predominantly inactive autolysins within the thickened cell wall, with greatly 
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reduced amounts released into the external environment, partly as a consequence of decreases in 
the net positive charge of the cell surface (Stapleton et al., 2007). As ECg modulates the levels of 
PBP1 and PBP3 in the staphylococcal CM, the molecule induces a 5-10% reduction in peptidoglycan 
cross-linking without compromising cell integrity (Stapleton et al., 2007) resulting in a less dense 
appearance of the wall and greater packed cell volume of ECg-treated bacteria (Bernal et al., 2009). 
Abrogation of resistance of MRSA to β-lactam antibiotics 
Although the changes described above shed light on some aspects of the complex ECg-induced 
MRSA phenotype, they are unlikely to account for the large increases in β-lactam susceptibility 
induced by exposure to ECg. Low to moderate concentrations of ECg and other catechin gallates 
elicit complete restoration of β-lactam susceptibility, that we believe can only be a consequence of 
direct interference with the underlying antibiotic resistance machinery of the cell. The β-lactam 
resistance determinant PBP2a is localised during MRSA cell division at the septum within the 
macromolecular division machinery, the divisome (Fig. 2), a complex composed primarily of 
membrane-bound proteins but also including cytoplasmic components. Central to orderly 
staphylococcal division are the PBPs that transglycosylate and cross-link nascent peptidoglycan 
chains through transpeptidation reactions. Thus, PBPs catalyse the insertion and crosslinking of 
newly synthesized peptidoglycan precursors into the cell wall and are the targets for β-lactam 
antibiotics (Ehlert, 1999). These antibiotics function as analogues of D-alanyl-D-alanine 
peptidoglycan side chain termini, the normal substrates for the PBPs, to form a long-lived covalent 
acyl-enzyme complex that inactivates the enzyme, leading to loss of cell wall cross-linking, cell lysis 
and death. 
Cell division is initiated by polymerisation into a filamentous Z-ring structure of the cytosolic 
tubulin homologue protein FtsZ, a self-activating guanosine triphosphatase (Adams and Errington, 
2009). FtsZ recruits further divisome proteins to the septum, including the essential component 
PBP2, a bifunctional protein with spatially well-separated transglycosylase and transpeptidase 
domains that is essential for the expression of the β-lactam-resistant MRSA phenotype (Lovering et 
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al., 2007). In β-lactam susceptible S. aureus (MSSA), β-lactam drugs such as oxacillin prevent the 
recruitment of PBP2 to the septal site of cell division and the protein is dispersed over the entire 
surface of the viable cell (Pinho and Errington, 2005). The origins of SCCmec, the mobile genetic 
island staphylococcal cassette chromosome mec containing the mecA gene, are unclear but it may 
have been acquired by a MSSA strain from the animal pathogen Staphylococcus sciuri (Fuda et al., 
2005). The mecA gene product PBP2a is a high molecular weight membrane-bound transpeptidase 
that is not susceptible to acylation by β-lactam antibiotics and functions cooperatively with PBP2 in 
the presence of these drugs to compensate for the loss of PBP2 transpeptidase activity due to active 
site acylation. Thus, MRSA continues to cross-link peptidoglycan chains in the presence of β-lactams 
albeit with reduced efficiency. We found that intercalation of ECg into the MRSA CM delocalised 
PBP2 from the cell wall biosynthetic machinery and led to its dispersal over the entire membrane 
(Bernal et al., 2010). It was not possible, for technical reasons, to determine if PBP2a was similarly 
dispersed but use of novel detergent-free extraction procedures provided strong evidence of the 
predicted physical association between PBP2 and PBP2a and of an altered spatial relationship 
between the two membrane-embedded proteins following exposure to ECg (Paulin et al., 2014). It 
appears highly probable, therefore, that ECg abrogates β-lactam resistance in MRSA by physical and 
functional disruption of the PBP2/PBP2a complex, decoupling transglycosylation and 
transpeptidation from the septal site of cell wall peptidoglycan biosynthesis, preventing 
peptidoglycan cross-linking and leading to loss of structural rigidity and cell lysis driven by the high 
internal turgor pressure of the staphylococcal cell. In support of this contention, we found no 
evidence that ECg interacts directly with PBP2a to reduce its capacity to compensate for loss of PBP2 
function. 
A role for catechin gallates in the treatment of MRSA infections? 
The galloyl catechins possess substantial anti-oxidant properties but their biological activity is 
determined predominantly by their capacity to intercalate into lipid bilayers. Their safety profile is 
attractive and is underpinned by thousands of years of tea consumption. Catechins, like many 
8 
 
flavonoids, are subject to chemical transformation, both in vitro and in vivo. ECg and other catechin 
gallates are unstable in alkaline solution, degrading in minutes (Zhu et al., 1997), but are more stable 
in an acidic environment (Pomponio et al., 2003). EGCg degrades in phosphate buffer over the pH 
range 6.5-7.8 to yield several products, including the dimeric compounds theasinensin A and 
theasinensin D (Hatano et al., 2003), major oxidation products found in black tea. ECg was not 
investigated by these authors but it is likely to show similar modification. These compounds 
contribute to the distinctive dark colouration of black tea following a complex series of oxidative 
structural modifications (Tanaka et al., 2010). Recovery by centrifugation of MRSA cells exposed to 
ECg indicated that both intact cells (Fig. 3) and the CM fraction displayed a dark pigmentation as 
little as 5 min after addition of the catechin gallate, suggesting that ECg incorporated into the CM 
lipid palisade undergoes spontaneous oxidation or is subject to modification by CM enzymes. This 
interesting observation should be explored further as it implies that the ECg-induced MRSA 
phenotype results from membrane interactions involving metabolites or oxidation products of ECg 
and not from the unmodified compound. In this context, it is interesting to note that Hatano and co-
workers demonstrated that EGCg-derived theasensin A is a potent modifier of resistance to oxacillin 
(Hatano et al., 2003). 
Catechin gallates are rapidly metabolised to inactive products by intestinal bacteria after 
oral administration (Kohri et al., 2001) due to the presence of an esterase susceptible bond linking 
the B-ring to the A-C fused ring system (for structures of naurally occurring and synthetic catechins, 
see Palacios et al., 2014)). After in vivo removal of the galloyl group from EGCg, EGC undergoes 
reduction, cleavage, dehydroxylation, further decomposition and lactonisation to form 
hydroxyphenyl-γ-valerolactone products that are excreted in urine and faeces (Kohri et al., 2001). 
We have replaced the hydrolytically susceptible ester bond in ECg with an amide linkage that 
stabilises the molecule by preventing the initial cleavage step (Anderson et al., 2005a). Such 
modifications, together with rearrangements of B-ring hydroxyl group substitutions (Anderson et al., 
2005b; 2011; 2014) that increase resistance-modifying potential, should improve the attractiveness 
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of these compounds as therapeutic adjuncts. In addition to substantial biotransformation, rates of 
absorption and bioavailability are low, at least in the case of orally administered EGCg. Systemic 
availability of EGCg in human volunteers increase with oral dose and low to moderate levels were 
detected in plasma (Chow et al., 2001); other catechins were not investigated in this study but 
administration of Polyphenon E, a commercial decaffeinated green tea catechin mixture, led to 
lower concentrations of EGC and EC in the blood compared to EGCg. Oral bioavailability of catechin 
gallates in human subjects is enhanced by administration after overnight fasting, which is likely to 
increase the biological response to the agent (Chow et al., 2005). Absorption, plasma bioavailability 
and biotransformation have also been investigated in rodents, with a complex and variable 
pharmacokinetic profile comparable to human data (Yang et al., 2008). 
In spite of suboptimal structure-activity relationships and poor pharmacokinetic profile, 
EGCg has been examined for its antioxidant, anti-inflammatory and anti-atherogenic properties in 
randomised controlled human clinical trials with variable, conflicting and generally disappointing 
outcomes (National Cancer Institute, 2016; Mereles and Hunstein, 2011; Farrar et al., 2015).  In the 
anti-infective domain, human trials support the anticaryogenic efficacy of green tea consumption 
(reviewed in Taylor et al., 2005), but no clinical trials have been undertaken to investigate the 
efficacy of green tea components in more serious microbial infections. Similarly, there have been 
very few attempts to examine green tea components in animal models of infection. Lee and 
colleagues examined the capacity of green tea extracts to resolve chronic induced experimental 
bacterial prostatitis in the adult rat with inconclusive results with regard to bacterial numbers at the 
infection site, chronic local inflammation, acinar change and intestinal fibrosis (Lee et al., 2005). In 
light of rapid biotranformation of catechin gallates after oral or systemic dosing, we were reluctant 
to undertake efficacy experiments in vertebrates with the native compounds but we recently 
examined the capacity of ECg to resolve MRSA infections in the zebrafish embryo (Stevens et al., 
2015), a model of infection that would enable us to circumvent many of the pharmacokinetic issues 
described above. Embryos injected into the yolk sac 30 h after fertilisation with strain EMRSA-16 
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rapidly succumbed to lethal infection whereas the majority of embryos survived a similar challenge 
dose (1-5 × 103 CFU) injected into the circulation valley. No significant increases in survival were 
noted when infected embryos were maintained in 12.5-100 µg/ml ECg with or without oxacillin. 
However, when EMRSA-16 was grown in the presence of 12.5 µg/ml ECg and the bacteria used to 
infect embryos by either the circulation valley or yolk sac, there were significant increases in embryo 
survival in both the presence and absence of oxacillin. Thus, exposure to ECg prior to infection 
reduced the lethality of EMRSA-16, rendered cells more susceptible to elimination by immune 
processes and compromised their capacity to establish an inflammatory response, but the lack of 
capacity to alter the course of established infection with unmodified bacteria indicates that in this 
infection model ECg is unable to function either as a therapeutic that modifies staphylococcal 
virulence or as an adjunct to conventional β-lactam chemotherapy. Clearly, further investigations are 
needed to resolve the antibacterial potential of ECg and other catechin gallates. 
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Legends 
Figure 1: Scanning electron micrographs of mid-logarithmic growth phase EMRSA-16 (A) and  
EMRSA-16 grown in the presence of 12.5 mg/l ECg (B). 
 
Figure 2: Proteins of the divisome recruited to the division septum of MRSA during cell division. 
Cytoplasmic synthesis of lipid II, the peptidoglycan precursor polymerised by PBPs, is also shown in 
the not-to-scale representation. A full description of the enzymatic steps involved can be found in 
the review by Barreteau et al. (2008). Figure kindly provided by Dr Sarah Paulin. 
 
Figure 3: Appearance of pellets of EMRSA-16 cells after 5 min (A) and 4 h (B) growth in the presence 
and absence (control) of 12.5 mg/l ECg. 
 
 
 
 
 
 
 
 
 
 
 
 
 
